Ritonavir and disulfiram have potential to inhibit caspase-1 mediated inflammation and reduce neurological sequelae after minor blast exposure

Kevin Foley, Richard E. Kast, Eric L. Altschuler

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Caspase-1 triggers cytokine release following acceleration-induced concussive head injury. Minor blast injury in which no physical tissue injury occurs, results in the release of cytokines in a similar fashion. Ritonavir, a generically available protease inhibitor with a benign short-term side-effect profile, has been shown to inhibit expression of caspase-1. We review the relevant literature and propose that ritonavir may be of benefit in reducing adverse neuropsychiatric outcomes and hastening recovery following mild blast injury. Further research in animal models of blast injury followed by clinical studies would determine whether this therapy is effective.

Original languageEnglish
Pages (from-to)150-152
Number of pages3
JournalMedical Hypotheses
Volume72
Issue number2
DOIs
StatePublished - Feb 2009
Externally publishedYes

Fingerprint

Dive into the research topics of 'Ritonavir and disulfiram have potential to inhibit caspase-1 mediated inflammation and reduce neurological sequelae after minor blast exposure'. Together they form a unique fingerprint.

Cite this